RN7SL736P

Across TCGA pan-cancer cohorts, RN7SL736P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RN7SL736P’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RN7SL736P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL736P is over-expressed in tumor.

BLCA, LUAD, and HNSC are the cancer types where RN7SL736P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL736P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	III,IV	+0.185	.034	3	view →
LUAD	All	All	+0.435	.011	2	view →
HNSC	All	All	+0.056	.040	2	view →
STAD	Male	III,IV	+0.345	.014	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RN7SL736P–BLCA

Open the BLCA breakdown →